$CYCU

Cycurion, Inc.

2
3
0

No SEC Form 4 filings for $CYCU in the last 30 days.

See all $CYCU insider activity →
Med

Cycurion (CYCU) pairs reverse split with decade-long HHS deal

Cycurion (CYCU) announced a 1-for-8 reverse stock split and a 10-year, $54.6M deal with HHS, expected to generate over $5M in annual recurring revenue. The company reported improved gross margins (29.1% in Q2 2026 vs. 6.1% in Q2 2025) and reduced net debt. Management targets profitability by Q2 2027 and authorized a $500K share repurchase program.

Cycurion reports margin expansion, signs $54.6M contract

Cycurion (NASDAQ:CYCU) reported Q2 2026 gross margin expansion to 29.1% from 6.1% in Q2 2025, reduced net debt by over half since 2024, and signed a $54.6M 10-year contract with HHS. The company expects $15M-$17M in committed revenue annually from 2026-2028 and aims for break-even operations by Q2 2027. It also completed two acquisitions and authorized a $500K share repurchase program.

Cycurion, Inc. Announces Reverse Stock Split Effective August 28, 2026

Cycurion, Inc. (NASDAQ: CYCU) announced a 1-for-8 reverse stock split effective August 28, 2026, to meet Nasdaq's minimum bid price requirement. The split reduces outstanding shares from ~25.8M to ~3.2M, with fractional shares compensated in cash. Shareholder approval was obtained in July 2026.

CYCU sentiment & insider activity

Over the past 7 days, alphai's AI scored 5 news stories mentioning CYCU (Cycurion, Inc.). Coverage has skewed bullish: 2 bullish, 3 neutral, and 0 bearish.

Recent CYCU coverage spans corporate actions, technology and financial news.

What's driving CYCU

  • The split could lift the share price by reducing float, while the multi‑year contract adds revenue visibility.

    stocktitan.net · Aug 28, 2026

  • The reverse split may improve liquidity and meet listing standards; the large contract adds >$5M annual recurring revenue, supporting break‑even targets for Q2 2027.

    investing.com · Aug 26, 2026

  • The reverse split will reduce share count and raise the share price, potentially attracting institutional investors and preventing delisting.

    finanznachrichten.de · Aug 26, 2026

  • The filing adds transparency but shows no insider activity, likely minimal price impact.

    stocktitan.net · Aug 20, 2026

  • Strong earnings beat and margin expansion suggest near‑term upside; the new contract and buyback add further bullish catalysts.

    prlog.org · Aug 20, 2026

alphai scores every news story that mentions CYCU with an AI model for sentiment and relevance, and aggregates insider trades from Cycurion, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CYCU

Score
$CYCUMed

Cycurion reports margin expansion, signs $54.6M contract

Cycurion (NASDAQ:CYCU) reported Q2 2026 gross margin expansion to 29.1% from 6.1% in Q2 2025, reduced net debt by over half since 2024, and signed a $54.6M 10-year contract with HHS. The company expects $15M-$17M in committed revenue annually from 2026-2028 and aims for break-even operations by Q2 2027. It also completed two acquisitions and authorized a $500K share repurchase program.

$CYCUMed

5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate

Cycurion, Inc. (CYCU) reported Q2 2026 revenue of $3.8M, beating estimates, with a 5X gross margin improvement. The company secured a $54.6M 10-year contract and acquired Kustom's video solutions, adding $5M in annual revenue. CYCU also announced a $500K share repurchase program and patent extensions for its security technology.

$CYCULow

Cycurion Announces Share Repurchase Amid Growth Initiatives - TipRanks.com

Cycurion's board authorized a $500,000 share repurchase program over 12 months, citing undervaluation. The move follows recent acquisitions and a large contract, expected to boost annual revenue to $30M. Management aims to balance buybacks with growth and integration needs. Analysts have mixed views, with a Buy rating and $7.00 price target, while TipRanks' AI rates it Neutral due to financial performance concerns.

$CYCULow

Cycurion receives patent for fleet driver analytics technology

Cycurion Inc. (NASDAQ: CYCU) received U.S. Patent No. 12,705,983 for fleet driver analytics technology, part of its Digital Ally acquisition. The patent enables tracking, incident mapping, and driver performance analysis for fleet operators. Cycurion now holds over 50 related patents and aims to expand into the global telematics market, estimated at over $100 billion. The company serves over 800 clients and plans to integrate the technology with its existing product suite.

Related tickers